{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:37:47Z","timestamp":1793716667642,"version":"4.6.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004543","name":"Chinese Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004241","name":"Eleventh Five-year Plan in Health Care Foundation of PLA","doi-asserted-by":"publisher","award":["09BJZ04"],"award-info":[{"award-number":["09BJZ04"]}],"id":[{"id":"10.13039\/501100004241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30940070"],"award-info":[{"award-number":["30940070"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL-65998"],"award-info":[{"award-number":["HL-65998"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL-111775"],"award-info":[{"award-number":["HL-111775"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.atherosclerosis.2017.05.006","type":"journal-article","created":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T15:40:24Z","timestamp":1493998824000},"page":"205-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Hyperhomocysteinaemia is an independent risk factor for peripheral arterial disease in a Chinese Han population"],"prefix":"10.1016","volume":"263","author":[{"given":"Dan","family":"Rong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniah","family":"AL-Nafisee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senhao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongpeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raouf A.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.atherosclerosis.2017.05.006_bib1","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMcp1507631","article-title":"Clinical practice. Peripheral artery disease","volume":"374","author":"Kullo","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"9901","key":"10.1016\/j.atherosclerosis.2017.05.006_bib2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.05.006_bib3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/ije\/25.2.282","article-title":"The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease","volume":"25","author":"Stoffers","year":"1996","journal-title":"Int. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.05.006_bib4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis","volume":"295","author":"Bhatt","year":"2006","journal-title":"JAMA"},{"issue":"41","key":"10.1016\/j.atherosclerosis.2017.05.006_bib5","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/eurheartj\/ehu080","article-title":"Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry","volume":"35","author":"Kumbhani","year":"2014","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.05.006_bib6","first-page":"111","article-title":"Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis","volume":"56","author":"McCully","year":"1969","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.05.006_bib7","first-page":"473","article-title":"Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy","volume":"114","author":"Ueland","year":"1989","journal-title":"J.\u00a0Lab. Clin. Med."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.05.006_bib8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nm0496-386","article-title":"Homocysteine and vascular disease","volume":"2","author":"McCully","year":"1996","journal-title":"Nat. Med."},{"issue":"15","key":"10.1016\/j.atherosclerosis.2017.05.006_bib9","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","article-title":"Homocysteine and atherothrombosis","volume":"338","author":"Welch","year":"1998","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.05.006_bib10","first-page":"S72","article-title":"Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients","volume":"41","author":"Chauveau","year":"1993","journal-title":"Kidney Int. Suppl."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.05.006_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0002-9343(94)90149-X","article-title":"Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies","volume":"96","author":"Savage","year":"1994","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.05.006_bib12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0735-1097(95)00508-0","article-title":"Homocysteine and coronary atherosclerosis","volume":"27","author":"Mayer","year":"1996","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"13","key":"10.1016\/j.atherosclerosis.2017.05.006_bib13","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A\u00a0quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.atherosclerosis.2017.05.006_bib14","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","article-title":"Hyperhomocysteinemia: an independent risk factor for vascular disease","volume":"324","author":"Clarke","year":"1991","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.05.006_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0021-9150(90)90058-Q","article-title":"Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment","volume":"81","author":"Brattstrom","year":"1990","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.05.006_bib16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0950-821X(05)80255-5","article-title":"Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50\u2013effect of smoking and extent of disease","volume":"7","author":"Bergmark","year":"1993","journal-title":"Eur. J. Vasc. Surg."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.05.006_bib17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejvs.2009.05.007","article-title":"Homocysteine and peripheral arterial disease: systematic review and meta-analysis","volume":"38","author":"Khandanpour","year":"2009","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.05.006_bib18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s100169900037","article-title":"Fasting total plasma homocysteine and atherosclerotic peripheral vascular disease","volume":"11","author":"Cheng","year":"1997","journal-title":"Ann. Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2017.05.006_bib19","doi-asserted-by":"crossref","first-page":"17966","DOI":"10.1038\/srep17966","article-title":"Hyperhomocysteinaemia is an independent risk factor of abdominal aortic aneurysm in a Chinese Han population","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"issue":"24","key":"10.1016\/j.atherosclerosis.2017.05.006_bib20","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1161\/CIR.0b013e318276fbcb","article-title":"Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association","volume":"126","author":"Aboyans","year":"2012","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2017.05.006_bib21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00392-012-0471-z","article-title":"Automated photoplethysmography-based determination of ankle-brachial index: a validation study against Doppler sonography","volume":"101","author":"Beutner","year":"2012","journal-title":"Clin. Res. Cardiol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2017.05.006_bib22","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jclinepi.2006.01.014","article-title":"Review: a gentle introduction to imputation of missing values","volume":"59","author":"Donders","year":"2006","journal-title":"J.\u00a0Clin. Epidemiol."},{"issue":"19","key":"10.1016\/j.atherosclerosis.2017.05.006_bib23","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1001\/jama.285.19.2481","article-title":"Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease","volume":"285","author":"Ridker","year":"2001","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2017.05.006_bib24","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1161\/CIRCULATIONAHA.105.608679","article-title":"Risk factors for progression of peripheral arterial disease in large and small vessels","volume":"113","author":"Aboyans","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.05.006_bib25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0741-5214(91)90020-U","article-title":"The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease","volume":"13","author":"Taylor","year":"1991","journal-title":"J.\u00a0Vasc. Surg."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.05.006_bib26","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.107.719369","article-title":"Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk","volume":"117","author":"Pradhan","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.05.006_bib27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.atherosclerosis.2014.04.010","article-title":"Plasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease","volume":"235","author":"Bertoia","year":"2014","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.05.006_bib28","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1053\/meta.2001.23286","article-title":"Factors explaining the difference of total homocysteine between men and women in the European Investigation into Cancer and Nutrition Potsdam study","volume":"50","author":"Dierkes","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2017.05.006_bib29","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.freeradbiomed.2013.07.041","article-title":"Mass spectrometry evidence for formation of estrogen\u2013homocysteine conjugates: estrogens can regulate homocysteine levels","volume":"65","author":"Gaikwad","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2017.05.006_bib30","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00008571-200210000-00003","article-title":"Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation","volume":"12","author":"Goodman","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.atherosclerosis.2017.05.006_bib31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ab.2014.08.013","article-title":"Using S-adenosyl-L-homocysteine capture compounds to characterize S-adenosyl-L-methionine and S-adenosyl-L-homocysteine binding proteins","volume":"467","author":"Brown","year":"2014","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.05.006_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1586\/17512433.2015.1010516","article-title":"Homocysteine and the pathogenesis of atherosclerosis","volume":"8","author":"McCully","year":"2015","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.05.006_bib33","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1017\/S0029665108007076","article-title":"Homocysteine, B-vitamins and CVD","volume":"67","author":"McNulty","year":"2008","journal-title":"Proc. Nutr. Soc."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.05.006_bib34","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jvs.2008.10.004","article-title":"Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: a case-control study and meta-analysis","volume":"49","author":"Khandanpour","year":"2009","journal-title":"J.\u00a0Vasc. Surg."},{"issue":"13","key":"10.1016\/j.atherosclerosis.2017.05.006_bib35","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jama.2015.2274","article-title":"Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China","volume":"313","author":"Huo","year":"2015","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2017.05.006_bib36","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"18","key":"10.1016\/j.atherosclerosis.2017.05.006_bib37","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/archinternmed.2010.348","article-title":"Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37485 individuals","volume":"170","author":"Clarke","year":"2010","journal-title":"Arch. Intern Med."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017301958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017301958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:38:10Z","timestamp":1758155890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017301958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":37,"alternative-id":["S0021915017301958"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.05.006","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperhomocysteinaemia is an independent risk factor for peripheral arterial disease in a Chinese Han population","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}